THE Cancer Council NSW and the University of NSW (UNSW) have entered into a $40 million, 10-year partnership to launch a cancer survivorship centre this Thu.
The Australian Research Centre for Cancer Survivorship (ARCCS) will be the first research facility in the world dedicated solely to understanding and improving life after cancer.
Led by international cancer expert Professor Bogda Koczwara, the centre will advance research to improve outcomes for survivors - informing practice, services and policy across Australia and helping people to thrive, irrespective of stage or type of cancer.
The centre will work with consumers, primary care and industry to design, test and implement new models of survivorship support, with a focus on addressing inequities in regional and rural communities.
"Through our existing work to support those living with and beyond a cancer diagnosis, we have identified a distinct need for research tailored to people navigating this 'new normal', to enhance quality of life," said Cancer Council NSW chief executive officer Professor Sarah Hosking.
"The launch of the Australian Research Centre for Cancer Survivorship, under the leadership of Professor Bogda Koczwara, is a vital step for Cancer Council NSW as we work to ensure better support, better care and ultimately better quality of life for cancer survivors, through an evidence-based approach and world-class researchers," Hosking said.
Koczwara added: "This centre is for those affected by cancer and it is here because we understand that cancer survivorship comes at a price."
"It can lead to physical, psychological, emotional and financial problems.
"We must create a world where each and every cancer survivor is supported through the delivery of personalised care," she added.
Australia has become a global leader in cancer survival, with more than 1.6 million Australians living with and beyond cancer.
ARCCS's launch coincides with World Cancer Day tomorrow. JM
The above article was sent to subscribers in Pharmacy Daily's issue from 03 Feb 26
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 03 Feb 26
